Aiken v. United States

30 A.3d 127, 2011 D.C. App. LEXIS 606, 2011 WL 4975171
CourtDistrict of Columbia Court of Appeals
DecidedOctober 20, 2011
Docket09-CO-0656, 09-CO-0657
StatusPublished
Cited by2 cases

This text of 30 A.3d 127 (Aiken v. United States) is published on Counsel Stack Legal Research, covering District of Columbia Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Aiken v. United States, 30 A.3d 127, 2011 D.C. App. LEXIS 606, 2011 WL 4975171 (D.C. 2011).

Opinion

THOMPSON, Associate Judge:

In 2001, appellant Kenneth Aiken was convicted of committing a series of felony and misdemeanor offenses against his former girlfriend, Patricia Parker, in 2000. On appeal to this court, he sought relief from those convictions on a number of grounds, including that his trial counsel provided ineffective assistance by failing to request a so-called Kastigar 1 hearing, at which the government would be required to prove that its evidence at trial would not include evidence derived from immunized testimony that appellant gave at a hearing on Parker’s petition for a civil protection order (“CPO”). We concluded that appellant had made “a more than colorable showing of deficient performance” by his counsel in failing to request a Kastigar hearing, and we held that appellant was entitled to a hearing to determine whether the government had made use of his immunized testimony at trial and, if so, whether the use “was harmless beyond a reasonable doubt in light of the strength of the government’s case.”. Aiken v. United States (Aiken I), 956 A.2d 38, 49-50 (D.C.2008).

The trial court held the Kastigar hearing in December 2008. Afterward, in an April 27, 2009 order (“Order”), the trial court ruled that the government had met its burden of proving that “none of the government’s evidence was tainted by [appellant’s] CPO testimony.” Appellant now appeals from that ruling, arguing that the trial court clearly erred in so finding. We agree with appellant that the government did not meet its burden to prove by a preponderance of the evidence that no use *131 was made of his immunized testimony. We also conclude that as to three of appellant’s convictions — his conviction of an alleged August 22, 2000 felony threat (Count 6) and two of his misdemeanor destruction of property convictions (Counts 8 and 9)— the use made of his immunized testimony was not harmless beyond a reasonable doubt. Accordingly, we conclude that appellant is entitled to reversal of his convictions of those charged offenses.

1. Procedural History and Background

This case arose from a series of threats, harassing telephone calls, and assaults allegedly committed by appellant against Parker beginning in March 2000. On September 26, 2000, a hearing was held on Parker’s request for a CPO. At the conclusion of the CPO hearing, at which both appellant and Parker testified, the trial court issued a CPO directing appellant to stay away from Parker.

In December 2000, appellant was indicted for escape from a halfway house, and on January 3, 2001, he was charged in a separate 15-count indictment with numerous offenses against Parker (including some that were committed after issuance of the CPO). 2 The cases were joined for trial. On January 30, 2001, a jury found appellant guilty of felony threats (three counts), felony destruction of property, stalking, and simple assault. The court found appellant guilty of simple assault, five counts of misdemeanor destruction of property, and two counts of violating a protective order. Appellant was sentenced to an aggregate term of 14 years of imprisonment.

There followed appellant’s direct appeal, his D.C.Code § 23-110 motion alleging ineffective assistance of counsel, his appeal from the trial court’s denial of that motion, and this court’s decision in Aiken I remanding for the Kastigar hearing. In its Order issued on April 27, 2009 (as amended nunc pro tunc on May 19, 2009), the trial court found that appellant’s immunized testimony “was not used to refresh memories, focus thoughts, organize testimony, or alter witnesses’ statements,” was “not used for non-evidentiary purposes such as focusing an investigation, refusing to plea bargain, interpreting evidence, planning trial strategy, or planning cross-examination,” and “did not alter, shape, or affect witness testimony or [appellant’s] prosecution.”

In his appeal from that Order, appellant asserts that the government failed to prove that the prosecution of his case was not tainted by the police detective’s and the prosecutor’s exposure to (or exposure to information about) his immunized testimony. He also argues that the evidence the government presented at trial — primarily through the testimony of Parker, who heard his testimony at the CPO hearing — contained new facts, details, and explanations that were prompted by that immunized testimony and that “added depth to [Parker’s] story,” “significantly strengthened the credibility of her allegations,” ascribed a motive to appellant for one of the alleged offenses, and bolstered *132 the testimony of the government’s witnesses by pre-empting defense challenges to their credibility. He contends that he was prejudiced by these impermissible uses of his immunized testimony (which, he asserts, would have been excluded had his counsel provided effective representation and requested a pre-trial Kastigar hearing) and that he therefore is entitled to reversal of his convictions.

II. Applicable Law

We begin with a discussion of the law that guides our analysis. At the time of the CPO hearing, D.C.Code § 16-1002(c) provided in pertinent part that “[tjestimony of the respondent in any civil proceeding under this subchapter [including a CPO hearing] and the fruits of that testimony shall be inadmissible as evidence in a criminal trial except in a prosecution for perjury or false statement.” 3 In Aiken I, we reasoned that even though § 16-1002(c) did not compel testimony by the respondent in a CPO proceeding, its purpose was “to enable (if not to compel) witnesses to testify (in CPO hearings) without losing, in effect, the benefits of the privilege against self-incrimination.” 956 A.2d at 44. We noted that in Kastigar, the Supreme Court held that where a statutory grant of immunity affords a protection “coextensive” with the protection furnished by the Fifth Amendment privilege against self-incrimination, it “imposes on the prosecution the affirmative duty to prove that the evidence it proposefs] to use is derived from a legitimate source wholly independent of [a defendant’s] compelled testimony.” Kastigar, 406 U.S. at 453, 460, 92 S.Ct. 1653; see Aiken I, 956 A.2d at 44. We held that the government bore the same burden under § 16-1002(c) — i.e., that the government had the burden of proving that it did not make direct or derivative use of a defendant’s immunized testimony by “demonstrating] that it obtained all of the evidence it ... use[d] from sources independent of the compelled testimony.” Aiken I, 956 A.2d at 45 (quoting United States v. North (North I), 910 F.2d 843, 854 (D.C.Cir.1990)) (internal quotation marks omitted).

As we noted in Aiken I, “[m]ost courts following Kastigar

Free access — add to your briefcase to read the full text and ask questions with AI

Related

State v. Quigley
2016 WI App 53 (Court of Appeals of Wisconsin, 2016)
Porter v. United States
37 A.3d 251 (District of Columbia Court of Appeals, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
30 A.3d 127, 2011 D.C. App. LEXIS 606, 2011 WL 4975171, Counsel Stack Legal Research, https://law.counselstack.com/opinion/aiken-v-united-states-dc-2011.